Evotec (NASDAQ:EVO) Shares Gap Down – Here’s Why

Evotec SE (NASDAQ:EVO)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $3.34, but opened at $3.19. Evotec shares last traded at $3.22, with a volume of 8,429 shares trading hands.

Evotec Stock Performance

The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.99 and a current ratio of 2.09. The firm has a 50-day moving average of $4.04 and a 200 day moving average of $4.10.

Institutional Trading of Evotec

Several large investors have recently made changes to their positions in the company. Wellington Management Group LLP boosted its holdings in Evotec by 29.7% in the third quarter. Wellington Management Group LLP now owns 2,634,434 shares of the company’s stock worth $9,616,000 after acquiring an additional 602,858 shares in the last quarter. Lighthouse Investment Partners LLC acquired a new position in shares of Evotec during the fourth quarter worth approximately $166,000. DCF Advisers LLC lifted its holdings in shares of Evotec by 5.9% in the 4th quarter. DCF Advisers LLC now owns 229,871 shares of the company’s stock worth $956,000 after purchasing an additional 12,816 shares in the last quarter. CSS LLC IL bought a new stake in Evotec during the 4th quarter worth approximately $50,000. Finally, Bank of America Corp DE boosted its holdings in Evotec by 262.5% during the 4th quarter. Bank of America Corp DE now owns 12,828 shares of the company’s stock worth $53,000 after acquiring an additional 9,289 shares during the last quarter. 5.81% of the stock is currently owned by institutional investors and hedge funds.

Evotec Company Profile

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women’s health.